Cargando…

Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study

PURPOSE: Anorexia nervosa (AN) is a severe psychiatric disorder, and shape and weight concerns are often chronic despite weight normalization. No specific treatments exist for those preoccupations that interfere with recovery and trigger relapse. A case study using a ketogenic diet followed by ketam...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Lori, Scolnick, Barbara, Zupec-Kania, Beth, Beckwith, Caroline, Costello, Kayla, Frank, Guido K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803738/
https://www.ncbi.nlm.nih.gov/pubmed/35997954
http://dx.doi.org/10.1007/s40519-022-01455-x
_version_ 1784861950539202560
author Calabrese, Lori
Scolnick, Barbara
Zupec-Kania, Beth
Beckwith, Caroline
Costello, Kayla
Frank, Guido K. W.
author_facet Calabrese, Lori
Scolnick, Barbara
Zupec-Kania, Beth
Beckwith, Caroline
Costello, Kayla
Frank, Guido K. W.
author_sort Calabrese, Lori
collection PubMed
description PURPOSE: Anorexia nervosa (AN) is a severe psychiatric disorder, and shape and weight concerns are often chronic despite weight normalization. No specific treatments exist for those preoccupations that interfere with recovery and trigger relapse. A case study using a ketogenic diet followed by ketamine infusions led to sustained remission in one patient with chronic AN. Here we conducted an open-label trial to test whether this response could be replicated. METHODS: Five adults weight recovered from AN but with persistent eating disorder thoughts and behaviors adopted a therapeutic ketogenic diet (TKD) aimed at maintaining weight. After sustaining nutritional ketosis, participants received six ketamine infusions and were followed over 6 months. RESULTS: All participants completed the study protocol without significant adverse effects. Two participants maintained TKD for 8 weeks prior to ketamine infusions due to good behavioral response and remained on TKD. Three participants received TKD for 4 weeks prior to and during ketamine, then tapered off after the final infusion. The group showed significant improvements on the Clinical Impairment Assessment (p = 0.008), Eating Disorder Examination Questionnaire (EDEQ) Global score (p = 0.006), EDEQ-Eating Concerns (p = 0.005), EDEQ-Shape Concerns (p = 0.016), EDEQ-Weight Concerns (p = 0.032), Eating Disorders Recovery Questionnaire (EDRQ) Acceptance of Self and Body (0.027) and EDRQ-Social and Emotional Connection (p = 0.001). Weight remained stable, except for one participant who relapsed 4 months after treatment and off TKD. CONCLUSION: This novel treatment appears to be safe and effective for adults with chronic AN-related psychopathology. The results from this open trial support that there are specific neurobiological underpinnings of AN that can be normalized using TKD and ketamine. LEVEL OF EVIDENCE: Level IV, multiple time series with intervention SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40519-022-01455-x.
format Online
Article
Text
id pubmed-9803738
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98037382023-01-01 Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study Calabrese, Lori Scolnick, Barbara Zupec-Kania, Beth Beckwith, Caroline Costello, Kayla Frank, Guido K. W. Eat Weight Disord Brief Report PURPOSE: Anorexia nervosa (AN) is a severe psychiatric disorder, and shape and weight concerns are often chronic despite weight normalization. No specific treatments exist for those preoccupations that interfere with recovery and trigger relapse. A case study using a ketogenic diet followed by ketamine infusions led to sustained remission in one patient with chronic AN. Here we conducted an open-label trial to test whether this response could be replicated. METHODS: Five adults weight recovered from AN but with persistent eating disorder thoughts and behaviors adopted a therapeutic ketogenic diet (TKD) aimed at maintaining weight. After sustaining nutritional ketosis, participants received six ketamine infusions and were followed over 6 months. RESULTS: All participants completed the study protocol without significant adverse effects. Two participants maintained TKD for 8 weeks prior to ketamine infusions due to good behavioral response and remained on TKD. Three participants received TKD for 4 weeks prior to and during ketamine, then tapered off after the final infusion. The group showed significant improvements on the Clinical Impairment Assessment (p = 0.008), Eating Disorder Examination Questionnaire (EDEQ) Global score (p = 0.006), EDEQ-Eating Concerns (p = 0.005), EDEQ-Shape Concerns (p = 0.016), EDEQ-Weight Concerns (p = 0.032), Eating Disorders Recovery Questionnaire (EDRQ) Acceptance of Self and Body (0.027) and EDRQ-Social and Emotional Connection (p = 0.001). Weight remained stable, except for one participant who relapsed 4 months after treatment and off TKD. CONCLUSION: This novel treatment appears to be safe and effective for adults with chronic AN-related psychopathology. The results from this open trial support that there are specific neurobiological underpinnings of AN that can be normalized using TKD and ketamine. LEVEL OF EVIDENCE: Level IV, multiple time series with intervention SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40519-022-01455-x. Springer International Publishing 2022-08-23 2022 /pmc/articles/PMC9803738/ /pubmed/35997954 http://dx.doi.org/10.1007/s40519-022-01455-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Report
Calabrese, Lori
Scolnick, Barbara
Zupec-Kania, Beth
Beckwith, Caroline
Costello, Kayla
Frank, Guido K. W.
Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title_full Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title_fullStr Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title_full_unstemmed Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title_short Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
title_sort ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803738/
https://www.ncbi.nlm.nih.gov/pubmed/35997954
http://dx.doi.org/10.1007/s40519-022-01455-x
work_keys_str_mv AT calabreselori ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy
AT scolnickbarbara ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy
AT zupeckaniabeth ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy
AT beckwithcaroline ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy
AT costellokayla ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy
AT frankguidokw ketogenicdietandketamineinfusiontreatmenttotargetchronicpersistenteatingdisorderpsychopathologyinanorexianervosaapilotstudy